Parkinson's disease (PD) is the second most common neurodegenerative disorder
characterized by loss of dopaminergic (DAergic) neurons in the substantia nigra (SN) that …

Parkinson's disease (PD) is the second most common neurodegenerative disease and
affects approximately 2–3% of the population over the age of 65. PD is characterised by the …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. Among
its pathologies, progressive loss of dopaminergic (DA) neurons in the substantia nigra is …

Introduction: Parkinson's disease is a devastating neurodegenerative disorder preferentially
involving loss of dopaminergic neurons in the substantia nigra, leading to typical motor …

Parkinson's disease (PD) is the second most common neurodegenerative disease, with a
strong genetic component to both the familial and sporadic forms. The cardinal motor …

The prevalence and incidence of Parkinson's disease (PD) is increasing due to a prolonged
life expectancy. This highlights the need for a better mechanistic understanding and new …

Parkinson's Disease (PD) is a chronic neurodegenerative disorder characterized by motor
and non-motor symptoms, among which are bradykinesia, rigidity, tremor as well as mental …

Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with
characteristic movement impairments that are caused by the progressive loss of dopamine …

Progress in understanding neurodegenerative cell biology in Parkinson′ s disease (PD)
has been hampered by a lack of predictive and relevant cellular models. In addition, the lack …

Studying Parkinson's disease (PD) in the laboratory presents many challenges, the main
one being the limited availability of human cells and tissue from affected individuals. As PD …